BNP Paribas Financial Markets
ANRO icon

BNP Paribas Financial Markets’s Alto Neuroscience ANRO Stock Holding History

BNP Paribas Financial Markets’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Buy
3,880
+3,566
+1,136% +$82.5K ﹤0.01% 4529
2026
Q1 		$7.06K Sell
314
-32,921
-99% -$610K ﹤0.01% 5276
2025
Q4 		$592K Buy
33,235
+32,721
+6,366% +$412K ﹤0.01% 3478
2025
Q3 		$2.07K Sell
514
-291
-36% -$965 ﹤0.01% 5168
2025
Q2 		$1.77K Sell
805
-400
-33% -$952 ﹤0.01% 5073
2025
Q1 		$2.6K Sell
1,205
-41,315
-97% -$148K ﹤0.01% 4947
2024
Q4 		$180K Buy
42,520
+38,205
+885% +$238K ﹤0.01% 3929
2024
Q3 		$49.4K Buy
4,315
+3,715
+619% +$45.5K ﹤0.01% 3615
2024
Q2 		$6.41K Buy
+600
New +$7.81K ﹤0.01% 3753

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BNP Paribas Financial Markets's ANRO Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Alto Neuroscience (ANRO) stake by 1,136% in Q2 2026, buying an estimated $82.5K and bringing the position to 3,880 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #4529.

BNP Paribas Financial Markets first reported a position in ANRO in Q2 2024 and has held it in 9 quarters since. The position peaked at $592K in Q4 2025. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • BNP Paribas Financial Markets held 3,880 shares of Alto Neuroscience worth $102K as of Q2 2026.
  • BNP Paribas Financial Markets bought 3,566 Alto Neuroscience shares in Q2 2026, an estimated $82.5K.
  • Alto Neuroscience made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4529 holding.
  • BNP Paribas Financial Markets first reported a position in Alto Neuroscience in Q2 2024 and has held it in 9 quarters since.
  • BNP Paribas Financial Markets's Alto Neuroscience position peaked at $592K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.